[BREAKING] [Only] 99.8% of pancreatic cancer effect approved by Samsung Pharmaceutical & FDA

9 February Share

[BREAKING] [Only] 99.8% of pancreatic cancer effect approved by Samsung Pharmaceutical & FDA

[単独]サムスン製薬·FDA最終承認膵臓癌効果99.8%

[单独] 三星制药•FDA 最终认可的胰腺癌效果 99.8%

[FDA] Эффективность рака поджелудочной железы 99,8 %, конечно, окончательное одобрение FDA

[단독] 삼성제약•FDA 최종승인 췌장암 효과99.8% [More News]